Cite

    Alatorre, C. et al. (2017). Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide. Diabetes, obesity & metabolism. 19 (7), pp. 953-961. [Online].